Search results
Influencers Are Driving a New Category of Unionizing: Pharmacists
The Wall Street Journal· 3 days agoPharmacists have taken to social media, under handles like “The Accidental Pharmacist” and...
Percentage of Fortune 500 companies led by women stalls - Bizwomen
The Business Journals· 2 days agoWalmart is ranked as the No. 1 company by revenue for the 12th year in a row, followed by Amazon,...
NJIT Launches New Office of Corporate Engagement
New Jersey Business Magazine· 1 day agoNew Jersey Institute of Technology (NJIT) and its New Jersey Innovation Institute (NJII) have announced the establishment of a new Office of Corporate...
Need a pharmacy? These states and neighborhoods have less access | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 4 days agoOpening stores used to mean everything to pharmacy chains. CVS Health once boasted of opening or buying more than 2,900 locations in a five-year period.
FORTUNE ANNOUNCES 2024 FORTUNE 500
StreetInsider· 3 days agoWalmart, Amazon, Apple are top three on 70th annual Fortune 500 list NEW...
As pharmacies shutter, some Western states, Black and Latino communities are left behind
San Antonio Express-News· 4 days agoOpening stores used to mean everything to pharmacy chains. Now it’s shuttering hundreds, while...
The Tech Entrepreneurs Of Autism
Forbes· 4 days agoIn the early 2010s, a wave of tech start-ups arose with the goal of employing adults with autism, building on the claimed skills of these adults in...
'You’re the smoking cessation counselor, you’re the suicide prevention counselor'—waves of pharmacy...
Fortune· 4 days agoNow it’s shuttering hundreds, while Walgreens, Rite Aid and independent drugstores also pull back. “That trust, you just can’t quantify it,” said Omolola Adepoju, a University of Houston health ...
Pittsburgh loses 2 companies on the 2024 Fortune 500 list - Pittsburgh Business Times
The Business Journals· 3 days agoOn Tuesday, Fortune released its annual Fortune 500, a list of the biggest companies in the United...
AbbVie's tight grip on Humira market raises concerns about biosimilars
AOL· 7 hours agoHumira, which lists for almost $7,000 a month, is the first top-selling drug to compete with a slew of biosimilars, which are close but not exact copies of branded biologic medicines. But after ...
